Application of benzil monohydrazon-1-naphthaldehyde schiff base

The invention relates to the fields of medicinal chemistry and functional materials, in particular to application of schiff base formed by benzoyl dihydrazone or benzoyl monohydrazone with 1-naphthaldehyde through a reaction to anticancer and antibacterial drugs, medical materials, functional materi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: XING DIANXIANG, LIU SHUAI, TAN XUEJIE
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator XING DIANXIANG
LIU SHUAI
TAN XUEJIE
description The invention relates to the fields of medicinal chemistry and functional materials, in particular to application of schiff base formed by benzoyl dihydrazone or benzoyl monohydrazone with 1-naphthaldehyde through a reaction to anticancer and antibacterial drugs, medical materials, functional materials and other fields. Benzoyl dihydrazone-N,N'-bis(1-formyl naphthalene) is a pale yellow shuttle-like crystal in appearance with a melting point of 201.0-203.0 DEG C and the molecular formula of C36H26N4; and benzoyl monohydrazone-N-1-formyl naphthalene is a yellow lumpy crystal in appearance witha melting point of 135.2-136.7 DEG C and a molecular formula of C25H18N2O. The structures of the benzoyl dihydrazone-N, N'-bis(1-formyl naphthalene) and the benzoyl monohydrazone-N-1-formyl naphthalene are shown in the specifications. The two substances have certain inhibitory activity on lung cancer cells, breast cancer cells, escherichia coli and staphylococcus aureus and can be used in the antitumor and antibacterial d
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN110772506A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN110772506A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN110772506A3</originalsourceid><addsrcrecordid>eNrjZLB3LCjIyUxOLMnMz1PIT1NISs2rysxRyM3Py8-oTClKrMrP0zXUzUssyCjJSMxJSQUKpioUJ2dkpgHVJhan8jCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeGc_Q0MDc3MjUwMzR2Ni1AAAqr8xEQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Application of benzil monohydrazon-1-naphthaldehyde schiff base</title><source>esp@cenet</source><creator>XING DIANXIANG ; LIU SHUAI ; TAN XUEJIE</creator><creatorcontrib>XING DIANXIANG ; LIU SHUAI ; TAN XUEJIE</creatorcontrib><description>The invention relates to the fields of medicinal chemistry and functional materials, in particular to application of schiff base formed by benzoyl dihydrazone or benzoyl monohydrazone with 1-naphthaldehyde through a reaction to anticancer and antibacterial drugs, medical materials, functional materials and other fields. Benzoyl dihydrazone-N,N'-bis(1-formyl naphthalene) is a pale yellow shuttle-like crystal in appearance with a melting point of 201.0-203.0 DEG C and the molecular formula of C36H26N4; and benzoyl monohydrazone-N-1-formyl naphthalene is a yellow lumpy crystal in appearance witha melting point of 135.2-136.7 DEG C and a molecular formula of C25H18N2O. The structures of the benzoyl dihydrazone-N, N'-bis(1-formyl naphthalene) and the benzoyl monohydrazone-N-1-formyl naphthalene are shown in the specifications. The two substances have certain inhibitory activity on lung cancer cells, breast cancer cells, escherichia coli and staphylococcus aureus and can be used in the antitumor and antibacterial d</description><language>chi ; eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200211&amp;DB=EPODOC&amp;CC=CN&amp;NR=110772506A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200211&amp;DB=EPODOC&amp;CC=CN&amp;NR=110772506A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>XING DIANXIANG</creatorcontrib><creatorcontrib>LIU SHUAI</creatorcontrib><creatorcontrib>TAN XUEJIE</creatorcontrib><title>Application of benzil monohydrazon-1-naphthaldehyde schiff base</title><description>The invention relates to the fields of medicinal chemistry and functional materials, in particular to application of schiff base formed by benzoyl dihydrazone or benzoyl monohydrazone with 1-naphthaldehyde through a reaction to anticancer and antibacterial drugs, medical materials, functional materials and other fields. Benzoyl dihydrazone-N,N'-bis(1-formyl naphthalene) is a pale yellow shuttle-like crystal in appearance with a melting point of 201.0-203.0 DEG C and the molecular formula of C36H26N4; and benzoyl monohydrazone-N-1-formyl naphthalene is a yellow lumpy crystal in appearance witha melting point of 135.2-136.7 DEG C and a molecular formula of C25H18N2O. The structures of the benzoyl dihydrazone-N, N'-bis(1-formyl naphthalene) and the benzoyl monohydrazone-N-1-formyl naphthalene are shown in the specifications. The two substances have certain inhibitory activity on lung cancer cells, breast cancer cells, escherichia coli and staphylococcus aureus and can be used in the antitumor and antibacterial d</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB3LCjIyUxOLMnMz1PIT1NISs2rysxRyM3Py8-oTClKrMrP0zXUzUssyCjJSMxJSQUKpioUJ2dkpgHVJhan8jCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeGc_Q0MDc3MjUwMzR2Ni1AAAqr8xEQ</recordid><startdate>20200211</startdate><enddate>20200211</enddate><creator>XING DIANXIANG</creator><creator>LIU SHUAI</creator><creator>TAN XUEJIE</creator><scope>EVB</scope></search><sort><creationdate>20200211</creationdate><title>Application of benzil monohydrazon-1-naphthaldehyde schiff base</title><author>XING DIANXIANG ; LIU SHUAI ; TAN XUEJIE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN110772506A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2020</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>XING DIANXIANG</creatorcontrib><creatorcontrib>LIU SHUAI</creatorcontrib><creatorcontrib>TAN XUEJIE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>XING DIANXIANG</au><au>LIU SHUAI</au><au>TAN XUEJIE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Application of benzil monohydrazon-1-naphthaldehyde schiff base</title><date>2020-02-11</date><risdate>2020</risdate><abstract>The invention relates to the fields of medicinal chemistry and functional materials, in particular to application of schiff base formed by benzoyl dihydrazone or benzoyl monohydrazone with 1-naphthaldehyde through a reaction to anticancer and antibacterial drugs, medical materials, functional materials and other fields. Benzoyl dihydrazone-N,N'-bis(1-formyl naphthalene) is a pale yellow shuttle-like crystal in appearance with a melting point of 201.0-203.0 DEG C and the molecular formula of C36H26N4; and benzoyl monohydrazone-N-1-formyl naphthalene is a yellow lumpy crystal in appearance witha melting point of 135.2-136.7 DEG C and a molecular formula of C25H18N2O. The structures of the benzoyl dihydrazone-N, N'-bis(1-formyl naphthalene) and the benzoyl monohydrazone-N-1-formyl naphthalene are shown in the specifications. The two substances have certain inhibitory activity on lung cancer cells, breast cancer cells, escherichia coli and staphylococcus aureus and can be used in the antitumor and antibacterial d</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN110772506A
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Application of benzil monohydrazon-1-naphthaldehyde schiff base
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T00%3A03%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=XING%20DIANXIANG&rft.date=2020-02-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN110772506A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true